Michael S Saporito Selected Research

Michael S Saporito Research Topics

2	Type 2 Diabetes Mellitus (MODY) 07/2012 - 07/2012
1	Epilepsy (Aura) 01/2019
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019
1	Overactive Urinary Bladder (Overactive Bladder) 01/2016
1	Urinary Incontinence 01/2016
1	Seizures (Absence Seizure) 07/2014
1	Weight Gain 07/2012
1	Neoplasms (Cancer) 01/2011
1	Parkinson Disease (Parkinson's Disease) 04/2004
1	Neuroblastoma 04/2004
1	Alzheimer Disease (Alzheimer's Disease) 01/2002
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2002

3	Phosphotransferases (Kinase)IBA 07/2012 - 01/2002
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 07/2014
2	5-(3-methylphenoxy)-2(1H)-pyrimidinoneIBA 07/2012 - 07/2012
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Diazepam (Valium)FDA LinkGeneric 01/2019
1	ganaxoloneIBA 01/2019
1	LithiumIBA 01/2019
1	Pregnanolone (Allopregnanolone)IBA 01/2019
1	DiureticsIBA 01/2016
1	Furosemide (Lasix)FDA LinkGeneric 01/2016
1	Cholinergic Agents (Cholinergics)IBA 01/2016
1	Neuropeptide YIBA 07/2014
1	Insulin (Novolin)FDA Link 07/2012
1	Glucose (Dextrose)FDA LinkGeneric 07/2012
1	Rosiglitazone (Avandia)FDA Link 07/2012
1	Insulin ReceptorIBA 07/2012
1	Blood Glucose (Blood Sugar)IBA 07/2012
1	N- (3- (1H- indol- 4- yl)- 5- (2- methoxyisonicotinoyl)phenyl)methanesulfonamideIBA 01/2011
1	JNK Mitogen-Activated Protein KinasesIBA 04/2004
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2004
1	3,9-bis((ethylthio)methyl)-K-252aIBA 01/2002
1	Transcription Factors (Transcription Factor)IBA 01/2002

1	Therapeutics 07/2012